Today: 19 May 2026
Browse Category

NASDAQ:LIMN 3 February 2026

Liminatus Pharma (LIMN) jumps in premarket after late-session spike as Nasdaq $1 rule hangs over shares

Liminatus Pharma (LIMN) jumps in premarket after late-session spike as Nasdaq $1 rule hangs over shares

Liminatus Pharma shares jumped 29.4% to $0.74 in premarket trading Tuesday after surging 64.6% to $0.94 in Monday’s after-hours session. The stock remains below the $1 minimum required for Nasdaq listing, with the company facing a July 14, 2026 deadline to regain compliance. Liminatus disclosed it received a Nasdaq deficiency notice in January. Market cap stood near $15.5 million.
3 February 2026
·

Stock Market Today

  • Cerebras Systems IPO Surge and Volatility Explained
    May 19, 2026, 10:37 AM EDT. Cerebras Systems saw its initial public offering (IPO) price surge by 68% but has since entered a phase of significant volatility. This shift reflects fading enthusiasm after the buoyant debut of one of the year's biggest AI-related IPOs. Investors are weighing the company's future growth prospects amid a fluctuating market environment for tech stocks, particularly in the artificial intelligence sector. The initial surge underscored strong investor interest, but recent price swings highlight caution as the market reassesses valuations.

Latest articles

Snowflake Shares Jump Ahead of Results as Wall Street Bets on AI Demand

Snowflake Shares Jump Ahead of Results as Wall Street Bets on AI Demand

19 May 2026
Snowflake shares rose 6.3% to $174.62 in morning trading Tuesday, outperforming major U.S. index funds. BofA Securities raised its price target to $205, citing strong demand for Snowflake’s AI tools. The company reports fiscal first-quarter results after the U.S. market close on May 27. Trading volume reached 3.6 million shares, with a market value near $59.4 billion.
Agilysys Shares Rally After Strong Quarter; 2027 Guidance Catches Focus

Agilysys Shares Rally After Strong Quarter; 2027 Guidance Catches Focus

19 May 2026
Agilysys shares jumped 28% to $89.96 Tuesday after the company reported record fiscal fourth-quarter revenue of $82.9 million and projected 2027 revenue of $365 million to $370 million. Subscription revenue grew 30.2% for the year. Oppenheimer raised its price target to $100, while Needham kept a $120 target. Trading volume topped 555,000 shares, well above average.
Seagate Shares Dip Again as AI Storage Demand Pinches Supply

Seagate Shares Dip Again as AI Storage Demand Pinches Supply

19 May 2026
Seagate shares fell 2.3% to $723.81 Tuesday, extending Monday’s 6.87% drop after CEO Dave Mosley warned new factories would take too long to meet surging AI-driven demand for hard drives. Mosley said Seagate is boosting output by upgrading existing plants and technology, not building new facilities. Investors remain concerned about supply shortages despite strong revenue and cash flow.

Popular

Amesite Shares Rise Premarket After NurseMagic Signs Largest Client

Amesite Shares Rise Premarket After NurseMagic Signs Largest Client

19 May 2026
Amesite Inc. shares surged 218% to $2.50 in premarket trading after announcing its largest NurseMagic deployment with a 2,700-patient home-care client. The company disclosed $83,332 in quarterly revenue and a $678,061 net loss, with cash at $740,711 before a $2.2 million April financing. Amesite did not reveal the new contract’s value or customer name. Its latest filing cited “substantial doubt” about ongoing operations.
Go toTop